Results 31 to 40 of about 78,733 (162)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study

open access: yesJournal of Diabetes Investigation, 2020
Aims/Introduction Liraglutide and empagliflozin suppress cardiovascular events. However, reports on their long‐term combined use with insulin therapy or direct comparisons of these drugs are limited. Materials and Methods This open‐label, parallel‐group,
Hirotatsu Nakaguchi   +5 more
doaj   +1 more source

The effect of glycated hemoglobin variability on the development of microvascular complications in patients with type 1 diabetes

open access: yesМедицинский совет, 2020
Introduction. The results of a 25-year observational program to assess the effect of glycated hemoglobin variability on the development of microvascular complications in patients with type 1 diabetes mellitus are presented.Objective: This study aimed to ...
L. L. Bolotskaya   +3 more
doaj   +1 more source

Evaluating the Efficacy of New Structured Program for Teaching Patients with Diabetes Mellitus Type 1 in the Republic of Uzbekistan

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2014
Among 1245 patients with diabetes mellitus type 1 (children, adolescents and adults) by testing with the use of a questionnaire and determination of glycated hemoglobin we carried out evaluation of training conducted by coaches trained by new structured ...
A.B. Tashmanova   +3 more
doaj   +1 more source

Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study.

open access: yesPLoS Genetics, 2008
Type 2 diabetes is a leading cause of morbidity and mortality. While genetic variants have been found to influence the risk of type 2 diabetes mellitus, relatively few studies have focused on genes associated with glycated hemoglobin, an index of the ...
Guillaume Paré   +6 more
doaj   +1 more source

Measurement of glycated hemoglobin in a patient with homozygous hemoglobin E [PDF]

open access: yesClinical Chemistry and Laboratory Medicine, 2012
1 Pathology Queensland , Chemical PathologyPrincess Alexandra Hospital, Brisbane , Australia 2 School of Medicine , Southside Clinical School, The University of Queensland, Brisbane , Australia 3 Pathology Queensland , HaematologyPrincess Alexandra Hospital, Brisbane , Australia Keywords ...
Dimeski, Goce   +2 more
openaire   +5 more sources

Glycated albumin and glycated hemoglobin- A comparison

open access: yesInternational Journal of Biomedical Research, 2013
The progressive complications of unmanaged diabetes include heart disease, blindness, kidney failure, amputation of extremities due to circulation problems, and nerve disorders, as well as other chronic conditions. Decades of research have established that prolonged exposure to excess glucose is the cause of diabetes complications, and that long-term ...
Mukherjee, Brijesh   +2 more
openaire   +3 more sources

An incidental finding of a hemoglobin E variant in a diabetic patient with an abnormal glycated hemoglobin level: a case report

open access: yesJournal of Medical Case Reports
Background Glycated hemoglobin is a well-known marker for evaluating long-term glycemic control. However, the accuracy of glycated hemoglobin measurement can be affected by the presence of hemoglobin variants, which makes the determination and ...
Rashmi Karki   +3 more
doaj   +1 more source

Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study

open access: yesDrugs - Real World Outcomes, 2023
Background Type 2 diabetes mellitus is a chronic disease affecting millions of people worldwide. Achieving and maintaining glycemic control is essential to prevent or delay complications and different strategies are available as second-line treatment ...
Dan Ouchi   +6 more
doaj   +1 more source

Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin

open access: yesMedicina, 2021
Background and Objectives: Glycated hemoglobin (HbA1c) dosage is considered the gold standard in glycol-metabolic monitoring, but it presents limits, which can underestimate the glycemia trend. In this regard, it was introduced the glycated albumin (GA).
Francesca Gabriela Martino   +9 more
doaj   +1 more source

False measurement of glycated hemoglobin in patients without hemoglobin A [PDF]

open access: yesBioscience Reports, 2019
Abstract Background: Hemoglobin (Hb) A1c, a biochemical marker widely used in monitoring diabetes mellitus, can be quantitatively measured by various examining systems. However, significant errors still exist. In the present study, we evaluated the HbA1c level in five patients with compound heterozygotes by five different examining ...
Suo, Minghuan   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy